The top four countries or territories with the lowest ASRs of PUD in 2021. by Wende Hao (10315597)

Subjects:

Trends in the all-age numbers and age-standardized incidence, prevalence, mortality and DALYs rates of PUD by sex from 1990 to 2021. by Wende Hao (10315597)

Subjects:

Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 2021. by Wende Hao (10315597)

Subjects:

Proportion of PUD DALYs and deaths attributable to smoking by gender, SDI quintile, and GBD region in 1990 and 2021. by Wende Hao (10315597)

Subjects:

S1 File - Global burden and risk factors of peptic ulcer disease between 1990 and 2021: An analysis from the global burden of disease study 2021 by Wende Hao (10315597)

Subjects:

Numbers and age-standardized incidence, prevalence, deaths and DALYs rates of peptic ulcer disease in 1990. by Wende Hao (10315597)

Subjects:

The top four countries or territories with the highest ASRs of PUD in 2021. by Wende Hao (10315597)

Subjects:

Joinpoint regression analysis of the sex-specific ASRs for PUD globally from 1990 to 2021. by Wende Hao (10315597)

Subjects:

Predicted trends in Age-standardized rates of PUD for both sexes globally over the next 19 years (2022-2040). by Wende Hao (10315597)

Subjects:

Age-specific numbers and rates of PUD globally in 2021 for both sexes. by Wende Hao (10315597)

Subjects:

DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

“…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”

Based on our time series data(first from the left), the visualizations of linear residual predictions under different decimation rates (next three) show that as the decimation rate... by Hua Huo (1818133)

The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

Subjects:

Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

Subjects:

Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

Subjects:

Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. by Ningning Wang (560944)

Subjects:

The values of angiotensin II by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

Subjects:

General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

Subjects:

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

Subjects: